Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Pruritus | postmarketing | x | x | |
Erythema | postmarketing | x | x | |
Skin hyperpigmentation | postmarketing | x | x | |
Skin exfoliation | postmarketing | x | x | |
Dermatitis contact | x | x | ||
Application site reaction | x | |||
Dry skin | x | x | ||
Skin burning sensation | x | x | ||
Skin tenderness | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||
---|---|---|---|---|
Sensitisation | x | x | ||
Tinea pedis | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |